ALERE INC.
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $586.9M | $609.9M | $2.58B | $2.61B | $2.39B | $2.39B |
| Operating income | $32.3M | $30.1M | $94.7M | $146.6M | $156.9M | −$252.9M |
| Net income | −$6.1M | $210.0M | −$33.2M | −$75.0M | −$78.2M | −$133.5M |
| Total assets | $5.90B | $6.12B | $6.70B | $7.06B | $7.07B | $6.67B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $2.08B | $2.07B | $1.91B | $2.08B | $2.18B | $2.23B |
| EPS (diluted) | — | — | — | — | $-1.23 | $-1.58 |
| Shares out. | 86.7M | 84.5M | 82.5M | 81.2M | 80.3M | 85.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- 5.5%
- Net margin
- −1.0%
- Return on equity
- −0.3%
- Return on assets
- −0.1%
- Return on capital (ROCE)
- 0.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $24.00
- Revenue growth (YoY)
- −3.8%
- Net income growth (YoY)
- −102.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Accruals / assets
- −3.1%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Revenue declined year-over-year
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 11, 2017
- NT 10-Kmissed a reporting deadline ↗Mar 1, 2017
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2016
- NT 10-Qmissed a reporting deadline ↗May 11, 2016
- NT 10-Kmissed a reporting deadline ↗Feb 26, 2016
- NT 10-Qmissed a reporting deadline ↗May 12, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in controlOct 3, 2017
- Entered a material agreementSep 19, 2017
- Results of operationsAug 3, 2017
- Other material eventJul 21, 2017
- Entered a material agreementJul 17, 2017
- Shareholder vote · Other material eventJul 10, 2017
- Results of operationsJun 14, 2017
- Results of operationsJun 5, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.